吸入基托桑基纳米颗粒在肺癌治疗中的作用
Allana Carvalho Silva1, Mirsiane Pascoal Costa1, Thiago Medeiros Zacaron1
1Postgraduate Program in Pharmaceutical Science, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Minas Gerais, Brazil.
Pharmaceutics
|August 29, 2024
概括
使用奇托纳米颗粒的肺部药物输送通过增加肺部药物度和减少副作用来增强肺癌治疗. 这种方法可以提高药物透率和疗效,以获得更好的癌症治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 肺癌是全球癌症死亡的主要原因,目前的治疗方法受到肺部药物输送不足和全身毒性的限制.
- 肺部药物给药为直接向肺部提供了一个有希望的替代方案,旨在提高疗效和减少副作用.
- 肺部药物输送的挑战包括克服呼吸道的自然防御,这阻碍了药物的透和吸收.
研究的目的:
- 对基托桑基纳米颗粒的研究进行审查,以便在肺癌治疗中通过肺部输送抗癌药物.
- 探索纳米颗粒在克服肺障碍和提高药物疗效方面的潜力.
- 讨论新兴技术,如小干扰RNA (siRNA) 输送用于使用素纳米颗粒的肺癌治疗.
主要方法:
- 对肺癌肺部药物输送系统的科学文献的综述.
- 对纳米颗粒配方的分析,特别是基于酸盐的纳米颗粒,用于吸入药物输送.
- 检查研究的研究,调查使用素纳米颗粒提供抗癌药物和siRNA到肺部.
主要成果:
- 基于基托桑的纳米颗粒显示出由于其抗瘤活性和粘粘性特性,有望用于肺部药物输送.
- 纳米颗粒可以改善药物透到肺上皮,增强细胞吸收,并使药物释放得到控制.
- 研究表明,素纳米颗粒的潜力可以通过吸入提供传统的抗癌药物和新型治疗方法,如siRNA.
结论:
- 在吸入配方中加入基托桑基纳米颗粒代表了改善肺癌治疗疗效的可行策略.
- 使用这些纳米颗粒的抗癌药物的肺输送可以提高局部药物度,同时最大限度地降低全身毒性.
- 对素纳米粒子系统的进一步研究,包括用于siRNA传递的研究,对推进肺癌治疗具有重大潜力.
更多相关视频
05:55Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles
Published on: September 18, 2018
8.7K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
